TrialJAMA2018
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
Patrick N A Harris et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
391 papers cite itlatest 60 shown
this paperpooled ittrialcites it